References
- Fernandes C, Vanbever R. Preclinical models for pulmonary drug delivery. Expert Opin Drug Deliv 2009;6:1231–45
- Cryan S, Sivadas N, Garcia-Contreras L. In vivo animal models for drug delivery across the lung mucosal barrier. Adv Drug Deliv Rev 2007;59:1133–51
- Sakagami M. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev 2006;58:1030–60
- Patton J, Bryon P. Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov 2007;6:67–74
- Cipolla D, Gonda I. Formulation technology to repurpose drugs for inhalation delivery. Drug Discov Today: Ther Strateg 2011;8:123–30
- Driscoll K, Costa D, Hatch G, et al. Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations. Toxicol Sci 2000;55:24–35
- Raeburn D, Underwood S, Vilamil M. Techniques for drug delivery to the airways, and the assessment of lung function in animal models. J Pharmacol Toxicol Methods 1992;27:143–59
- Nahar K, Gupta N, Gauvin R, et al. In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals. Eur J Pharm Sci 2013;49:805–18
- Schreier H, McNicol K, Bennett D, et al. Pharmacokinetics of detirelix following intratracheal instillation and aerosol inhalation in the unanesthetized awake sheep. Pharm Res 1994;11:1056–9
- Duret C, Wauthoz N, Merlos R, et al. In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice. Eur J Pharm Biopharm 2012;81:627–34
- Morello M, Krone C, Dickerson S, et al. Dry-powder pulmonary insufflation in the mouse for application to vaccine or drug studies. Tuberculosis 2009;89:371–7
- Grainger C, Alcock R, Gard T, et al. Administration of an insulin powder to the lungs of cynomolgus monkeys using a Penn Century insufflator. Int J Pharm 2004;269:523–7
- Century J. The impact of intratracheal aerosol technologies on preclinical pulmonary research. Inhal Mag 2013;18:18–24
- Horodnik W, Sellers S, Wylie J, et al. The in vitro characterization of a novel preclinical dry powder delivery system consisting of an air pressurized capsule device (APCD) in combination with a pMDI spacer for endotracheal dosing. Proceedings from Respiratory Drug Delivery 2014:489–92
- Bennett D, Sievers R, Cape S, et al. The PuffHaler™: a simple active DPI with a pressure release valve disperser. Respiratory Drug Deliv 2008;2:345–50
- Horodnik W, Garber N, Ewing G, Donovan B. The in vitro delivery of a dry powder blend using pressurized air and a pMDI designed spacer and actuator combination product (aerochamber MV) into a ventilator circuit tubing and “short stack” Andersen cascade impactor (ACI) for particle size characterization. Respiratory Drug Deliv 2012;2:581–4
- Mitchell J, Nagel M, Doyle C, et al. Relative precision of inhaler aerodynamic particle size distribution (APSD) metrics by full resolution and abbreviated Andersen cascade impactors (ACIs): Part 1. AAPS PharmSciTech 2010;1:843–51
- Mechanics of respiration in unanesthetized guinea pigs. AMDUR MO, MEAD J. Am J Physiol 1958;192:364–8
- Kuehl P, Barrett E, McDonald J, et al. Formulation development and in vivo evaluation of a new dry powder formulation of albuterol sulphate in beagle dogs. Pharm Res 2010;27:894–904
- Kuehl P, Cherrington A, Dobry D, et al. Biologic comparison of inhaled insulin formulations: exubera and novel spray-dried engineered particles of dextran-10. AAPS PharmSciTech 2015;6:1545–50
- Rabinowitz J, Wensley M, Lloyd P, et al. Fast onset medications through thermally generated aerosols. J Pharmacol Exp Ther 2004;309:769–75